These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8421286)

  • 1. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.
    Bit RA; Davis PD; Elliott LH; Harris W; Hill CH; Keech E; Kumar H; Lawton G; Maw A; Nixon JS
    J Med Chem; 1993 Jan; 36(1):21-9. PubMed ID: 8421286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity.
    Davis PD; Elliott LH; Harris W; Hill CH; Hurst SA; Keech E; Kumar MK; Lawton G; Nixon JS; Wilkinson SE
    J Med Chem; 1992 Mar; 35(6):994-1001. PubMed ID: 1552513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.
    Wilkinson SE; Parker PJ; Nixon JS
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):335-7. PubMed ID: 8373348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
    Toullec D; Pianetti P; Coste H; Bellevergue P; Grand-Perret T; Ajakane M; Baudet V; Boissin P; Boursier E; Loriolle F
    J Biol Chem; 1991 Aug; 266(24):15771-81. PubMed ID: 1874734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activity.
    Nixon JS; Bishop J; Bradshaw D; Davis PD; Hill CH; Elliott LH; Kumar H; Lawton G; Lewis EJ; Mulqueen M
    Drugs Exp Clin Res; 1991; 17(8):389-93. PubMed ID: 1822831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
    Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
    J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta.
    Faul MM; Gillig JR; Jirousek MR; Ballas LM; Schotten T; Kahl A; Mohr M
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1857-9. PubMed ID: 12749884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages.
    Dieter P; Fitzke E
    Biochem Biophys Res Commun; 1991 Nov; 181(1):396-401. PubMed ID: 1958208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive multivariate analysis of bisindolylmaleimides as potent protein kinase C antagonists.
    Mager PP
    Drug Des Discov; 1993; 10(3):231-48. PubMed ID: 8268394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
    Zhang HC; White KB; Ye H; McComsey DF; Derian CK; Addo MF; Andrade-Gordon P; Eckardt AJ; Conway BR; Westover L; Xu JZ; Look R; Demarest KT; Emanuel S; Maryanoff BE
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3049-53. PubMed ID: 12941331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts.
    Jordan NJ; Watson ML; Yoshimura T; Westwick J
    Br J Pharmacol; 1996 Mar; 117(6):1245-53. PubMed ID: 8882622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides.
    Davis PD; Hill CH; Lawton G; Nixon JS; Wilkinson SE; Hurst SA; Keech E; Turner SE
    J Med Chem; 1992 Jan; 35(1):177-84. PubMed ID: 1732526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.
    Wang Q; Worland PJ; Clark JL; Carlson BA; Sausville EA
    Cell Growth Differ; 1995 Aug; 6(8):927-36. PubMed ID: 8547221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbial alkaloid toxin staurosporine blocks the phorbol ester-induced increase in beta-amyloid precursor protein in PC12 cells.
    Friedman LM; Matsuda Y; Lazarovici P
    Nat Toxins; 1997; 5(5):173-9. PubMed ID: 9496375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
    Courage C; Budworth J; Gescher A
    Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors.
    Brehmer D; Godl K; Zech B; Wissing J; Daub H
    Mol Cell Proteomics; 2004 May; 3(5):490-500. PubMed ID: 14769951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staurosporine and calphostin-C inhibit the phorbol ester-induced decrease of protein kinase C activity in rat hepatocytes.
    García-Sáinz JA; López-Gómez FJ; Robles-Flores M
    Biochem Int; 1992 Dec; 28(4):761-6. PubMed ID: 1282816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells.
    Mahata M; Mahapatra NR; O'Connor DT; Mahata SK
    Mol Pharmacol; 2002 Jun; 61(6):1340-7. PubMed ID: 12021395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
    Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
    Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of membrane redistribution of protein kinase C by its ATP-competitive inhibitors.
    Takahashi H; Namiki H
    Biochem J; 2007 Jul; 405(2):331-40. PubMed ID: 17373912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.